BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis and biological evaluation of novel glycosylated diphyllin derivatives as topoisomerase II inhibitors. 2012

Da-Kuo Shi, and Wei Zhang, and Ning Ding, and Ming Li, and Ying-Xia Li
School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.

Recently, a novel glycosylated diphyllin derivative 11 which exhibiting potent anticancer activity by targeting topoisomerase IIα was reported by our group. In order to provide more molecules for structure-activity relationship (SAR) studies, 12 new glycosylated diphyllin analogs have been designed, synthesized, and evaluated for their biological activities. The SAR analysis revealed that (i) the sugar moiety on the diphyllin is essential for the anticancer activity; (ii) equatorial C4'-OH on the sugar is superior to the axial one, and (iii) a proper cyclic lipophilic group at the C4' and C6' of sugar might enhance the anticancer activity.

UI MeSH Term Description Entries
D004148 Dioxolanes
D004250 DNA Topoisomerases, Type II DNA TOPOISOMERASES that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex. DNA Topoisomerase (ATP-Hydrolysing),DNA Topoisomerase II,DNA Topoisomerase II alpha,DNA Topoisomerase II beta,DNA Type 2 Topoisomerase,TOP2A Protein,TOP2B Protein,Topoisomerase II,Topoisomerase II alpha,Topoisomerase II beta,Type II DNA Topoisomerase,alpha, Topoisomerase II,beta, Topoisomerase II
D006031 Glycosylation The synthetic chemistry reaction or enzymatic reaction of adding carbohydrate or glycosyl groups. GLYCOSYLTRANSFERASES carry out the enzymatic glycosylation reactions. The spontaneous, non-enzymatic attachment of reducing sugars to free amino groups in proteins, lipids, or nucleic acids is called GLYCATION (see MAILLARD REACTION). Protein Glycosylation,Glycosylation, Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D017705 Lignans A class of dibenzylbutane derivatives which occurs in higher plants and in fluids (bile, serum, urine, etc.) in man and other animals. These compounds, which have a potential anti-cancer role, can be synthesized in vitro by human fecal flora. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Lignan,Neolignan,Neolignans
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D052117 Benzodioxoles Compounds based on benzene fused to oxole. They can be formed from methylated CATECHOLS such as EUGENOL. Methylenedioxybenzenes,1,3-Dioxaindans,1,3-Dioxindans,1,3 Dioxaindans,1,3 Dioxindans

Related Publications

Da-Kuo Shi, and Wei Zhang, and Ning Ding, and Ming Li, and Ying-Xia Li
Design, synthesis and biological evaluation of novel perimidine o-quinone derivatives as non-intercalative topoisomerase II catalytic inhibitors.
October 2019, Bioorganic chemistry,
Da-Kuo Shi, and Wei Zhang, and Ning Ding, and Ming Li, and Ying-Xia Li
Design, synthesis and biological evaluation of novel mansonone E derivatives prepared via CuAAC click chemistry as topoisomerase II inhibitors.
October 2013, European journal of medicinal chemistry,
Da-Kuo Shi, and Wei Zhang, and Ning Ding, and Ming Li, and Ying-Xia Li
Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors.
March 2015, European journal of medicinal chemistry,
Da-Kuo Shi, and Wei Zhang, and Ning Ding, and Ming Li, and Ying-Xia Li
Design, synthesis, and biological evaluation of novel urolithins derivatives as potential phosphodiesterase II inhibitors.
December 2021, Scientific reports,
Da-Kuo Shi, and Wei Zhang, and Ning Ding, and Ming Li, and Ying-Xia Li
Design, synthesis and biological evaluation of 3-substituted indenoisoquinoline derivatives as topoisomerase I inhibitors.
February 2016, Bioorganic & medicinal chemistry letters,
Da-Kuo Shi, and Wei Zhang, and Ning Ding, and Ming Li, and Ying-Xia Li
Design, Synthesis, and Anticancer Evaluation of Novel Indole Derivatives of Ursolic Acid as Potential Topoisomerase II Inhibitors.
April 2020, International journal of molecular sciences,
Da-Kuo Shi, and Wei Zhang, and Ning Ding, and Ming Li, and Ying-Xia Li
Design, synthesis, and biological evaluation of novel ciprofloxacin derivatives as potential anticancer agents targeting topoisomerase II enzyme.
December 2023, Journal of enzyme inhibition and medicinal chemistry,
Da-Kuo Shi, and Wei Zhang, and Ning Ding, and Ming Li, and Ying-Xia Li
Synthesis and biological evaluation of novel carbazole-rhodanine conjugates as topoisomerase II inhibitors.
May 2018, Bioorganic & medicinal chemistry letters,
Da-Kuo Shi, and Wei Zhang, and Ning Ding, and Ming Li, and Ying-Xia Li
Synthesis and evaluation of diphyllin β-hydroxyl amino derivatives as novel V-ATPase inhibitors.
October 2021, Chemical biology & drug design,
Da-Kuo Shi, and Wei Zhang, and Ning Ding, and Ming Li, and Ying-Xia Li
Design, synthesis and biological evaluation of benzimidazole-rhodanine conjugates as potent topoisomerase II inhibitors.
July 2018, MedChemComm,
Copied contents to your clipboard!